24. Acute pn

download 24. Acute pn

of 36

Transcript of 24. Acute pn

  • 7/27/2019 24. Acute pn

    1/36

    ACUTE PYELONEPHRITIS

  • 7/27/2019 24. Acute pn

    2/36

    Acute pyelonephritis is a potentially organ- and/or life-

    threatening infection that characteristically causes

    scarring of the kidney.An episode of acute pyelonephritis may lead to:

    kidney failure;

    abscess formation (eg, nephric, perinephric);

    sepsis

    septic shock,

    multiorgan system failure.

  • 7/27/2019 24. Acute pn

    3/36

    PathophysiologyAcute pyelonephritis results from bacter ia l invasion of the

    renal parenchyma.

    Bacteria usually reach the kidney by ascending from the

    lower urinary tract.

    In all age groups, episodes of bacteriuria occur commonly,

    but most are asymptomatic and do not lead to infection.

    The development of infection is influenced by bacterial

    factors and host factors. Bacteria may also reach the kidney via the

    bloodstreamMost bacterial data are derived from research with

    Escherichia coli, which accounts for 70-90% of

    uncomplicated UTIs and 21-54% of complicated UTIs

  • 7/27/2019 24. Acute pn

    4/36

    Pathogen

    s

    Staphylococcus

    saprophyticus

    Klebsiella pneumoniae

    Proteus mirabilis

    Enterococci

    S aureus

    Pseudomonas aeruginosa

    Enterobacter s ecies

  • 7/27/2019 24. Acute pn

    5/36

    Complicated infection

    Complicated UTI is an infection of the urinary tract in

    which the efficacy of antibiotics is reduced because ofthe presence of one or more of the following:

    Structural abnormalities of the urinary tract

    Functional abnormalities of the urinary tract

    Metabolic abnormalities predisposing to UTIs

    Unusual pathogens

    Recent antibiotic use

    Recent urinary tract instrumentation

  • 7/27/2019 24. Acute pn

    6/36

    Obstruction is the most important factor.

    It negates the flushing effect of urine flow; allows

    urine to pool (urinary stasis)=>providing bacteriaa medium in which to multiply;

    =>changes intrarenal blood

    flow, affecting neutrophil delivery.

    Obstruction may be extrinsic or intrinsic.

    Extrinsic obstruction : chronic constipation ,

    prostatic swelling/mass (eg, hypertrophy, infection,cancer), and retroperitoneal mass.

  • 7/27/2019 24. Acute pn

    7/36

    Intrinsic obstruction occurs with bladder outlet

    obstruction, cystocele, fungus ball, papillary necrosis,

    stricture, and urinary stones.

    Atrophic vaginal mucosa in postmenopausalwomen predisposes to the colonization of urinary

    tract pathogens and UTIs because of the higher pH

    (5.5 vs 3.8) and the absence of lactobacilli.

    Bacterial prostatitis (acute or chronic) produces

    bacteriuria,

  • 7/27/2019 24. Acute pn

    8/36

    Pregnancy produces hormonal and mechanical

    changes that predispose the woman to upper urinary

    traction infections.

    Hydroureter of pregnancy, secondary to both

    hormonal and mechanical factors, manifests

    as dilatation of the renal pelvis and ureters(greater on the left than on the right), with the

    ureters containing up to 200 mL of urine.

    Progesterone decreases ureteral peristalsisand increases bladder capacity.

    Diabetes mellit s prod ces a tonomic bladder ne ropath

  • 7/27/2019 24. Acute pn

    9/36

    Diabetes mellitus produces autonomic bladder neuropathy,

    glucosuria, leukocyte dysfunction, microangiopathy, and

    nephrosclerosis.

    Complicated UTIs in patients who have diabetes mellitus

    include the following:

    Renal and perirenal abscess

    Emphysematous pyelonephritis

    Emphysematous cystitis

    Fungal infections

    Xanthogranulomatous pyelonephritis

    Papillary necrosis

  • 7/27/2019 24. Acute pn

    10/36

    Bacteria % Uncomplicated % Complicated

    Gram negative

    Escherichia coli 70-95 21-54

    Proteus mirabilis 1-2 1-10

    Klebsiella spp 1-2 2-17

    Citrobacter spp < 1. 5

    Enterobacter spp < 1 2-10Pseudomonas aeruginosa < 1 2-19

    Other < 1 6-20

    Gram positive

    Coagulase-negative staphylococci 5-10 1-4Enterococci 1-2 1-23

    Group B streptococci < 1 1-4

    Staphylococcus aureus < 1 1-23

    Other < 1 2

  • 7/27/2019 24. Acute pn

    11/36

    History

    The classic presentation =triad : fever, costovertebral

    angle pain, and nausea and/or vomiting.

    Symptoms may be minimal to severe and usually

    develop over hours or over the course of a day.

    symptoms develop over several days and may even

    be present for a few weeks before the patient seeks

    medical care.

    Symptoms of cystitis : urinary frequency, hesitancy,

    lower abdominal pain, and urgency.

    G h t i (h h i titi ) i t i

  • 7/27/2019 24. Acute pn

    12/36

    Gross hematuria (hemorrhagic cystitis) is present in

    30-40% of pyelonephritis cases in females, most often

    young women.

    Gross hematuria is unusual in males and should

    prompt consideration of a more serious cause.

    Pain may be :

    mild, moderate, or severe

    unilateral /bilateral.

    in the back (lower or middle) and/or the suprapubicarea. Patients may describe suprapubic symptoms as

    discomfort, heaviness, pain, or pressure.

    Upper abdominal pain is unusual, and radiation of pain

    to the groin is suggestive of a ureteral stone.

  • 7/27/2019 24. Acute pn

    13/36

    Fever

    is not always present.

    it is not unusual for the temperature to exceed 103F

    (39.4C).

    Gastrointestinal symptoms.

    Anorexia is common.

    Nausea and vomiting vary in frequency and intensity

    from absent to severe.

    Diarrhea occurs infrequently.

  • 7/27/2019 24. Acute pn

    14/36

    Elderly patients may present with typical manifestations of

    pyelonephritis, or they may experience fever, mental status

    change, decompensation in another organ system, orgeneralized deterioration.

  • 7/27/2019 24. Acute pn

    15/36

    Complicated pyelonephritis

    A history of the following indicates an inc reased r is kof

    complicated pyelonephritis:

    Structural abnormalities of the urinary tract

    Functional abnormalities of the urinary tract

    Metabolic abnormalities predisposing to UTIs

    Recent antibiotic use

    Recent urinary tract instrumentation

  • 7/27/2019 24. Acute pn

    16/36

    abdominal examination:

    suprapubic tenderness usually ranges from mild tomoderate without rebound.

    Abdominal tenderness other than in the suprapubic

    area suggests another diagnosis.

    Patients usually do not have rigidity or guarding, and

    bowel sounds are often normally active.

    Flank or costovertebral angle (CVA) tenderness is mostcommonly unilateral over the involved kidney, although

    bilateral discomfort may be present.

  • 7/27/2019 24. Acute pn

    17/36

    In women: a pelvic examination should be performed.

    Tenderness of the cervix, uterus, and adnexa should be

    absent. Any positive finding suggests an additional or

    alternative diagnosis

  • 7/27/2019 24. Acute pn

    18/36

    Complications

    Complications occur more often in patients with diabetes

    mellitus, chronic renal disease, sickle cell disease, renal

    transplant (particularly during the first 3 months), AIDS,

    and other immunocompromised states.

    Complications may involve any of the following:

    Acute renal failure

    Chronic renal damage leading to hypertension and renal

    failure

    Sepsis syndromes

    Renal papillary

  • 7/27/2019 24. Acute pn

    19/36

    Acute Abdomen and

    Pregnancy

    Acute Bacterial Prostatitis

    Appendicitis

    Cervicitis

    Chronic Bacterial Prostatitis

    Chronic Pyelonephritis

    Cystitis in Females

    Endometritis

    Pelvic Inflammatory Disease

  • 7/27/2019 24. Acute pn

    20/36

    Approach Considerations

    In the outpatient setting, pyelonephritis is usuallysuggested by the history and physical examination

    and supported by urinalysis results, which should

    include microscopic analysis.

    Other laboratory studies are used to identifycomplicating conditions and to assist in determining

    whether the patient should be admitted.

    Easily diagnosed cases typically occur in women,both pregnant and nonpregnant.

  • 7/27/2019 24. Acute pn

    21/36

    Collection of Urine Specimens

    Urine specimens obtained for urinalysis and culture

    should approximate the urine contained in the bladderas closely as possible.

    The 3 procedures for collecting such a urine specimen

    are:

    clean catch,

    urethral catheterization,

    suprapubic needle aspiration.

  • 7/27/2019 24. Acute pn

    22/36

    Urinalysis

    Pyuria is defined as more than 5-10 WBCs per high-power field (hpf)on a specimen spun at 2000 rpm for 5 minutes. Almost all patients with

    pyelonephritis have significant pyuria (>20 WBCs/hpf).

    The dipstick leukocyte esterase test (LET) helps screen for pyuria.

    LET results have a sensitivity of 75-96% and a specificity of 94-98% fordetecting more than 10 WBC/hpf.

    The nitrite production test (NPT) for bacteriuria has 92-100%

    sensitivity and 35-85% specificity.

    Combined, the LET-NPT has a sensitivity of 79.2% and a specificity of81%, which is too low for it to be used as the only screening study for

    bacteriuria.

    Gross hematuria occurs infrequently with pyelonephritis

  • 7/27/2019 24. Acute pn

    23/36

    Gross hematuria occurs infrequently with pyelonephritis

    and is more common with cystitis (hemorrhagic cystitis).

    When gross hematuria is present, the differential should

    include calculi, cancer, glomerulonephritis, tuberculosis,trauma, and vasculitis.

    Microscopic hematuria may be present in patients with

    uncomplicated acute pyelonephritis, but other causes

    should be considered, particularly calculi

    Microscopic hematuria may be present in patients with

    uncomplicated acute pyelonephritis, but other causes should

    be considered, particularly calculi.

    White cell casts are suggestive of pyelonephritis

    Proteinuria is expected (up to 2 g/day). When it exceeds 3

    g/day, glomerulonephritis should be considered.

  • 7/27/2019 24. Acute pn

    24/36

    Urine and Blood CulturesUrine culture is indicated in any patient with pyelonephritis,

    whether treated in an inpatient or an outpatient setting,

    because of the possibility of antibiotic resistance.

    Blood cultures are indicated in any patient who is being

    admitted or who has already been admitted. Approximately

    12-20% of patients have cultures that are positive for

    infection

  • 7/27/2019 24. Acute pn

    25/36

    Indications for Imaging Studies

    Imaging may be required to make the diagnosis in infants

    and children in whom pyelonephritis presents insidiously.Imaging is warranted at the time of admission in patients

    with the following conditions:

    AIDSPoorly controlled diabetes

    Organ transplant (particularly renal)

    Other immunocompromised state

    Sepsis syndromeSeptic shock

    Indications for imaging studies are as follows:

  • 7/27/2019 24. Acute pn

    26/36

    Fever or positive blood culture results that persist for

    longer than 48 hours

    Sudden worsening of the patients condition

    Toxicity persisting for longer than 72 hours

    Complicated UTI

    Computed Tomography

  • 7/27/2019 24. Acute pn

    27/36

    Contrast-enhanced helical/spiral computed

    tomography (CECT) is the imaging study of choice,

    both in adults and in children with acute

    pyelonephritis.CECT is more sensitive than ultrasonography and

    intravenous pyelography (which has only 25%

    sensitivity), and it can more readily identify alterations

    in renal parenchymal perfusion, alterations in contrastexcretion, perinephric fluid, and nonrenal disease.

    Ultrasonography

    Ultrasonography (US) can sometimes detect acutepyelonephritis, but a negative study does not exclude

    the possibility.

  • 7/27/2019 24. Acute pn

    28/36

    CT and MR Urography

    CT urography and MR urography are evolving modalities

    that surpass intravenous urography, which was the prior

    mainstay of urinary tract imaging.

  • 7/27/2019 24. Acute pn

    29/36

    Approach Considerations

    Ambulatory younger women who present with signsand symptoms of uncomplicated acute pyelonephritis

    may be candidates for outpatient therapy. (They must

    be otherwise healthy and must not be pregnant.)

    In addition, they must be treated initially in theemergency department (ED) with vigorous oral or IV

    fluids, antipyretic pain medication, and a dose of

    parenteral antibiotics.

    Admission is usually appropriate for :

  • 7/27/2019 24. Acute pn

    30/36

    Admission is usually appropriate for :

    patients who are severely ill,

    pregnant,

    elderly

    who have comorbid disorders that increase thecomplexity of management or the complication rate

    (eg, diabetes mellitus, chronic lung disease, congenital

    or acquired immunodeficiency).

    Admission may also be advisable for patients whosesocial situation is unstable, because of the possibility of

    poor compliance or poor follow-up.

    Antibiotic Selection

  • 7/27/2019 24. Acute pn

    31/36

    Antibiotic Selection

    Antibiotic selection is typically empirical, because the

    results of blood or urine cultures are rarely available by

    the time a decision must be made.Initial selection should be guided by local antibiotic

    resistance patterns.

    Culture results from specimens collected before the

    initiation of therapy should be checked in 48 hours todetermine antibiotic efficacy.E coli or other Enterobacteriaceae => Acceptable

    regimens may include fluoroquinolones, cephalosporins,

    penicillins, extended-spectrum penicillins, carbapenems,

    and aminoglycosides.enterococci => ampicillin or vancomycin can replace the

    fluoroquinolone. If any doubt exists as to the diagnosis,

    coverage of both Enterobacteriaceae and enterococci is

    acceptable.

  • 7/27/2019 24. Acute pn

    32/36

    Regimens for complicated cases

    With complicated acute pyelonephritis, treat patients

    parenterally until defervescence and improvement in the clini

    condition warrants changing to oral antibiotics. Complete the

    course of therapy with an oral agent selected on the basis of

    culture results

    Acceptable regimens include the following:

    Ampicillin and an aminoglycoside

    Cefepime

    Imipenem

    MeropenemPiperacillin-tazobactam

    Ticarcillin-clavulanate

  • 7/27/2019 24. Acute pn

    33/36

    Outpatient Treatment

    Antibiotic therapy

    Patients presenting with acute pyelonephritis can be

    treated with a single dose of a parenteral antibioticfollowed by oral therapy, provided they are monitored

    within the first 48 hours.

  • 7/27/2019 24. Acute pn

    34/36

    First-line therapy

    ciprofloxacin (Cipro) 500 mg PO BID for 7d orciprofloxacin extended-release (Cipro XR) 1000 mg PO da

    for 7d or

    levofloxacin (Levaquin) 750 mg PO daily for 5d

    If fluoroquinolone resistance is thought to be >10%, administa single dose of ceftriaxone (Rocephin) 1g IV or a consolidat

    24-hour dose of an aminoglycoside (gentamicin 7 mg/kg IV o

    tobramycin 7 mg/kg IV or amikacin 20 mg/kg IV)

    cefaclor 500 mg PO TID for 7d

  • 7/27/2019 24. Acute pn

    35/36

    Second-line therapy

    trimethoprim/sulfamethoxazole* 160 mg/800 mg(Bactrim DS, Septra DS) 1 tablet PO BID for 14d

    If trimethoprim/sulfamethoxazole is used when the

    susceptibility is not known, an initial single IV dose of

    the following may also be given: ceftriaxone (Rocephin)1 g IV or a consolidated 24-h dose of an

    aminoglycoside (gentamicin 7 mg/kg IV or tobramycin 7

    mg/kg IV or amikacin 20 mg/kg IV)

  • 7/27/2019 24. Acute pn

    36/36

    Alternative therapy

    Oral beta-lactams are not as effective for treating

    pyelonephritis; however, if they are used, administerwith a single dose of ceftriaxone (Rocephin) 1 g IV or a

    consolidated 24-h dose of an aminoglycoside

    (gentamicin 7 mg/kg IV or tobramycin 7 mg/kg IV or

    amikacin 20 mg/kg IV)amoxicillin-clavulanate (Augmentin) 500 mg/125 mg

    PO BID for 14d or

    amoxicillin-clavulanate (Augmentin) 250 mg/125 mg

    PO TID for 3-7d orcefaclor 500 mg PO TID for 7d